Quantcast

Latest Cancer vaccines Stories

2014-09-09 08:32:26

DUBLIN, Sept. 9, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Human Vaccine Technologies Market" report to their offering. http://photos.prnewswire.com/prnvar/20130307/600769 Immunization is one of the highest impact and most cost effective methods of preventing infectious diseases, particularly in low and middle income countries with minimal healthcare facilities in remote locations. Many vaccines technologies that could aid improved safety, efficacy and...

2014-06-10 23:14:19

Christopher Shaw, PhD, a funded researcher by Children’s Medical Safety Research Institute (CMSRI), was mentioned in the Huffington Post for his stance regarding the cervical cancer vaccine. Fairfax, VA (PRWEB) June 10, 2014 Christopher Shaw, PhD, a scientific advisory board member of Children’s Medical Safety Research Institute (CMSRI), founded by Claire Dwoskin of the Dwoskin Family Foundation, was featured in Huffington Post, defending his stance regarding the cervical cancer...

2014-04-28 08:31:24

DUBLIN, Apr. 28, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/85rshn/global) has announced the addition of the "Global Therapeutic Vaccines Market 2014-2018" report to their offering. http://photos.prnewswire.com/prnh/20130307/600769 A therapeutic vaccine is a biological combination developed to improve immunity by inducing an attack against a diseased cell or tissue. This differs from prophylactic vaccines, which are administered to an individual...

2014-04-23 12:29:08

WORCESTER, Mass. and TORONTO, April 23, 2014 /PRNewswire/ -- Generex Biotechnology Corporation (www.generex.com) (OTCBB:GNBT) today announced that two abstracts in respect of results of the on-going Phase II study of a novel cancer vaccine designed to prevent relapse in patients who have had breast cancer will be presented at this year's American Society of Clinical Oncology (ASCO) Annual Meeting to be held in Chicago from May 30 to June 3, 2014. The ASCO Annual Meeting is the...

2014-04-23 08:31:00

Third Phase 3 Trial of Custirsen to Receive FDA Fast Track Designation BOTHELL, Wash. and VANCOUVER, British Columbia, April 23, 2014 /PRNewswire/ -- OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to the investigation of custirsen when administered in combination with cabazitaxel/prednisone for the treatment of men with metastatic castrate-resistant prostate cancer (CRPC) following...

2014-04-09 11:43:37

Small financial incentives, totaling as little as £30, can dramatically increase the likelihood of people who inject drugs completing a course of hepatitis B virus (HBV) vaccination, according to new research published in The Lancet. Researchers in the UK found that people undergoing treatment for heroin addiction who received a maximum total of £30 supermarket vouchers in equal or graduated installments in return for full compliance with a regimen of three HBV vaccine injections were at...

2014-03-25 23:30:00

Markets Research Reports.biz added deep and professional market research reports on "Global Cancer Vaccines Competitor Analysis And Market Research" Market Analysis and Overview. Albany, NY (PRWEB) March 25, 2014 The present Competitive Intelligence report about Cancer Vaccines provides a competitor evaluation in the field of novel prophylactic and therapeutic vaccines to fight cancer as of March 2014. Purchase of the downloadable pdf report includes a 6-month online access to...

2014-03-20 23:02:41

Researchers at UC Davis have found that the investigational cancer vaccine tecemotide, when administered with the chemotherapeutic cisplatin, boosted immune response and reduced the number of tumors in mice with lung cancer. Sacramento, CA (PRWEB) March 20, 2014 Researchers at UC Davis have found that the investigational cancer vaccine tecemotide, when administered with the chemotherapeutic cisplatin, boosted immune response and reduced the number of tumors in mice with lung cancer. The...

2014-03-17 04:21:39

BLUE BELL, Pa., March 17, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) today reported financial results for the fourth quarter and year ended December 31, 2013. Total revenue was $1.7 million and $13.5 million for the quarter and year ended December 31, 2013, as compared to $1.1 million and $4.1 million for the same periods in 2012. Total operating expenses for the quarter and year and ended December 31, 2013, were $9.7 million and $33.0 million as compared to...

2014-02-27 12:27:11

WORCESTER, Mass. and TORONTO, Feb. 27, 2014 /PRNewswire/ -- Generex Biotechnology Corporation (www.generex.com) (OTCBB:GNBT) today announced publication of studies examining potential biomarkers associated with overall survival in prostate cancer patients treated with its immunotherapeutic agent AE37. The retrospective study examined data from 29 patients immunized as part of a Phase I study. The immunotherapeutic agent AE37 is being developed by Antigen Express, Inc....


Word of the Day
caparison
  • A cloth or covering, more or less ornamented, laid over the saddle or furniture of a horse, especially of a sumpter-horse or horse of state.
  • Clothing, especially sumptuous clothing; equipment; outfit.
  • To cover with a caparison, as a horse.
  • To dress sumptuously; adorn with rich dress.
This word ultimately comes from the Medieval Latin 'cappa,' cloak.
Related